Add Yahoo as a preferred source to see more of our stories on Google. Zhongmou Therapeutics’ gene therapy for advanced retinitis pigmentosa (RP) has shown promise in a first-in-human trial. In the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results